Proteomic profile of uninvolved versus crescentic glomeruli in MPO-ANCA-associated vasculitis

被引:4
|
作者
Sethi, Amit [1 ]
Grande, Joseph [2 ]
Specks, Ulrich [3 ]
Fervenza, Fernando C. [1 ,4 ]
机构
[1] Univ Minnesota, Coll Liberal Arts, Minneapolis, MN 55455 USA
[2] Mayo Clin Coll Med & Sci, Dept Lab Med & Pathol, Div Anat Pathol, Rochester, MN USA
[3] Mayo Clin Coll Med & Sci, Dept Med, Div Pulm & Crit Care, Rochester, MN USA
[4] Mayo Clin Coll Med & Sci, Dept Med, Div Nephrol & Hypertens, Rochester, MN USA
关键词
D O I
10.1093/ckj/sfad030
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1180 / 1182
页数:3
相关论文
共 50 条
  • [31] Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study
    Ozaki, Shoichi
    Atsumi, Tatsuya
    Hayashi, Taichi
    Ishizu, Akihiro
    Kobayashi, Shigeto
    Kumagai, Shunichi
    Kurihara, Yasuyuki
    Kurokawa, Manae S.
    Makino, Hirofumi
    Nagafuchi, Hiroko
    Nakabayashi, Kimimasa
    Nishimoto, Norihiro
    Suka, Machi
    Tomino, Yasuhiko
    Yamada, Hidehiro
    Yamagata, Kunihiro
    Yoshida, Masaharu
    Yumura, Wako
    MODERN RHEUMATOLOGY, 2012, 22 (03) : 394 - 404
  • [32] Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis
    Hiroshi Maruyama
    Kouichi Hirayama
    Miho Nagai
    Itaru Ebihara
    Homare Shimohata
    Masaki Kobayashi
    Clinical Rheumatology, 2016, 35 : 2469 - 2476
  • [33] Serum decoy receptor 3 levels are associated with the disease activity of MPO-ANCA-associated renal vasculitis
    Maruyama, Hiroshi
    Hirayama, Kouichi
    Nagai, Miho
    Ebihara, Itaru
    Shimohata, Homare
    Kobayashi, Masaki
    CLINICAL RHEUMATOLOGY, 2016, 35 (10) : 2469 - 2476
  • [34] MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
    Obata, Shota
    Hidaka, Sumi
    Yamano, Mizuki
    Yanai, Mitsuru
    Ishioka, Kunihiro
    Kobayashi, Shuzo
    CLINICAL KIDNEY JOURNAL, 2022, 15 (02) : 357 - 359
  • [35] Spontaneous Corneal Perforation in Treatment-Resistant MPO-ANCA-Associated Small Vessel Vasculitis
    Zehnder, Karin
    Reinhold, Aja
    Gugleta, Konstantin
    Gatzioufas, Zisis
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2023, 240 (04) : 385 - 386
  • [36] From the Diagnosis of Pneumonia to Rituximab Therapy - MPO-ANCA-associated Vasculitis with pulmonary and renal Involvement
    Wanner, David
    Kronbichler, Andreas
    Hirsch, Markus
    Volderauer, N.
    Mayer, Gert
    Hackl, Martin
    Stein, Markus
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (19-20) : 599 - 600
  • [37] A novel mouse model for MPO-ANCA-associated glomerulonephritis
    Yumura, W
    Itabashi, M
    Ishida-Okawara, A
    Tomizawa, K
    Yamashita, J
    Kaneshiro, Y
    Nihei, H
    Suzuki, K
    MICROBIOLOGY AND IMMUNOLOGY, 2006, 50 (02) : 149 - 157
  • [38] Chlamydia pneumoniae infection and MPO-ANCA-associated glomerulonephritis
    Iyoda, Masayuki
    Kuroki, Aki
    Sugisaki, Tetsuzo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (03) : 965 - 966
  • [39] -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis
    Reynolds, WF
    Stegeman, CA
    Tervaert, JWC
    CLINICAL IMMUNOLOGY, 2002, 103 (02) : 154 - 160
  • [40] IgG4-and MPO-ANCA-associated hypertrophic pachymeningitis
    Aragones, Josep M.
    Arias-Rivero, Montserrat
    Garcia-Barrionuevo, Joan M.
    Lucchetti, Gianni
    REVISTA DE NEUROLOGIA, 2015, 61 (10) : 454 - 457